Braxia Scientific Corp C.BRAX

Alternate Symbol(s): BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.

CSE:BRAX - Post by User

Braxia Scientific Corp

Bullboard Posts

Comment by Bofovom1on Jun 22, 2020 10:30pm

455 Views

Post# 31179232

RE:RE:RE:New interview with Dr. McIntyre

Either this took place today and they omitted to include the halt in their discussion or it’s from a few days ago. There is certainly a lot of things needing explaining at this point, but I’m going to ride this out. It would be very unlikely that someone of Dr. mcIntyre’s stature would be part of any sort of scam or pump and dump, and much more likely that this was a oversite(incredibly costly). Very much looking forward to some updates on the halt, spinoff, and name change

Cheers

Bullboard Posts

Cybin launches new program phase to treat Major Depressive Disorder